- URL: http://xtalks.com/Tumor-Assessment-in-Immunotherapy-Clinical-Trials.ashx
- Date: September 19, 2016
- Listed: August 19, 2016 7:51 am
- Expires: This ad has expired
This webinar will give an overview of endpoint assessment as it relates to RECIST, irRC, and clinical benefit in the setting of cancer immunotherapy. Recommendations on when and how to apply each criterion will be reviewed as will case histories illustrating the clinical decision-making needed to determine if a patient should continue treatment.
Information about the ad poster
- Listed by: email@example.com
- Member Since: July 15, 2016
Other items listed by firstname.lastname@example.org
- Shipper Return & Reuse – Making It Work For Clinical Trials
- Is Site Payment Escrow a Thing of the Past?
- Pharmaceutical Case Studies that Illustrate a Data Strategy for Developing Better Medicines
- NAFLD/NASH – Race to the Market: Strategies and Tactics to Address Unmet Needs
- Avoid Patent Eclipse – Accelerate Your Study Start Up and Tracking